Details for Patent: 11,938,136
Which drugs does patent 11,938,136 protect, and when does it expire?
Patent 11,938,136 protects EVRYSDI and is included in one NDA.
This patent has twenty patent family members in fifteen countries.
Summary for Patent: 11,938,136
| Title: | Compositions for treating spinal muscular atrophy |
| Abstract: | The present invention provides pharmaceutical compositions comprising a compound of formula (I) |
| Inventor(s): | Jochem Alsenz, Olaf Grassmann, Peter Kuehl, Friedrich Metzger, Kathleen Dorothy McCarthy, Eduardo Paulo Morawski Vianna, Marvin Lloyd Woodhouse |
| Assignee: | Hoffmann La Roche Inc |
| Application Number: | US16/685,431 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,938,136 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Device; |
Drugs Protected by US Patent 11,938,136
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | EVRYSDI | risdiplam | FOR SOLUTION;ORAL | 213535-001 | Aug 7, 2020 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,938,136
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 106717 | ⤷ Start Trial | |||
| Australia | 2016353961 | ⤷ Start Trial | |||
| Brazil | 112018009281 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
